Literature DB >> 32485235

LTP-like cortical plasticity predicts conversion to dementia in patients with memory impairment.

Francesco Di Lorenzo1, Caterina Motta2, Elias Paolo Casula1, Sonia Bonnì1, Martina Assogna1, Carlo Caltagirone1, Alessandro Martorana2, Giacomo Koch3.   

Abstract

BACKGROUND: New diagnostic criteria consider Alzheimer's disease (AD) as a clinico-biological entity identifiable in vivo on the presence of specific patterns of CSF biomarkers.
OBJECTIVE: Here we used transcranial magnetic stimulation to investigate the mechanisms of cortical plasticity and sensory-motor integration in patients with hippocampal-type memory impairment admitted for the first time in the memory clinic stratified according to CSF biomarkers profile.
METHODS: Seventy-three patients were recruited and divided in three groups according to the new diagnostic criteria: 1) Mild Cognitive Impaired (MCI) patients (n = 21); Prodromal AD (PROAD) patients (n = 24); AD with manifest dementia (ADD) patients (n = 28). At time of recruitment all patients underwent CSF sampling for diagnostic purposes. Repetitive and paired-pulse transcranial magnetic stimulation protocols were performed to investigate LTP-like and LTD-like cortical plasticity, short intracortical inhibition (SICI) and short afferent inhibition (SAI). Patients were the followed up during three years to monitor the clinical progression or the conversion to dementia.
RESULTS: MCI patients showed a moderate but significant impairment of LTP-like cortical plasticity, while ADD and PROAD groups showed a more severe loss of LTP-like cortical plasticity. No differences were observed for LTD-like cortical plasticity, SICI and SAI protocols. Kaplan-Meyer analyses showed that PROAD and MCI patients converting to dementia had weaker LTP-like plasticity at time of first evaluation.
CONCLUSION: LTP-like cortical plasticity could be a novel biomarker to predict the clinical progression to dementia in patients with memory impairment at prodromal stages of AD identifiable with the new diagnostic criteria based on CSF biomarkers.
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; Biomarker; Long term potentiation; Memory; Mild cognitive impairment; TMS; Transcranial magnetic stimulation

Year:  2020        PMID: 32485235     DOI: 10.1016/j.brs.2020.05.013

Source DB:  PubMed          Journal:  Brain Stimul        ISSN: 1876-4754            Impact factor:   8.955


  12 in total

Review 1.  The therapeutic efficacy of transcranial magnetic stimulation in managing Alzheimer's disease: A systemic review and meta-analysis.

Authors:  Zhenyu Wei; Jiaqi Fu; Huazheng Liang; Mingli Liu; Xiaofei Ye; Ping Zhong
Journal:  Front Aging Neurosci       Date:  2022-09-06       Impact factor: 5.702

Review 2.  Modulating Frontal Networks' Timing-Dependent-Like Plasticity With Paired Associative Stimulation Protocols: Recent Advances and Future Perspectives.

Authors:  Giacomo Guidali; Camilla Roncoroni; Nadia Bolognini
Journal:  Front Hum Neurosci       Date:  2021-04-22       Impact factor: 3.169

Review 3.  Modulation of Brain Hyperexcitability: Potential New Therapeutic Approaches in Alzheimer's Disease.

Authors:  Sofia Toniolo; Arjune Sen; Masud Husain
Journal:  Int J Mol Sci       Date:  2020-12-07       Impact factor: 5.923

4.  Improved spatio-temporal measurements of visually evoked fields using optically-pumped magnetometers.

Authors:  Aikaterini Gialopsou; Christopher Abel; T M James; Thomas Coussens; Mark G Bason; Reuben Puddy; Francesco Di Lorenzo; Katharina Rolfs; Jens Voigt; Tilmann Sander; Mara Cercignani; Peter Krüger
Journal:  Sci Rep       Date:  2021-11-17       Impact factor: 4.379

5.  Editorial: Non-invasive Brain Stimulation for Neurodegenerative Disorders: From Investigation to Therapeutic Application.

Authors:  Francesco Di Lorenzo; Antonio Oliviero; Andrea Guerra; Peter J Fried
Journal:  Front Neurol       Date:  2022-03-03       Impact factor: 4.003

6.  Improvement of poststroke cognitive impairment by intermittent theta bursts: A double-blind randomized controlled trial.

Authors:  Wen Li; Qian Wen; Yu-Han Xie; An-Li Hu; Qing Wu; Yin-Xu Wang
Journal:  Brain Behav       Date:  2022-04-29       Impact factor: 3.405

Review 7.  Role of Ca2+/Calmodulin-Dependent Protein Kinase Type II in Mediating Function and Dysfunction at Glutamatergic Synapses.

Authors:  Archana G Mohanan; Sowmya Gunasekaran; Reena Sarah Jacob; R V Omkumar
Journal:  Front Mol Neurosci       Date:  2022-06-20       Impact factor: 6.261

Review 8.  Synaptic Effects of Palmitoylethanolamide in Neurodegenerative Disorders.

Authors:  Martina Assogna; Francesco Di Lorenzo; Alessandro Martorana; Giacomo Koch
Journal:  Biomolecules       Date:  2022-08-22

9.  Differences Changes in Cerebellar Functional Connectivity Between Mild Cognitive Impairment and Alzheimer's Disease: A Seed-Based Approach.

Authors:  Fanyu Tang; Donglin Zhu; Wenying Ma; Qun Yao; Qian Li; Jingping Shi
Journal:  Front Neurol       Date:  2021-06-17       Impact factor: 4.003

10.  Synaptic Plasticity and Oscillations in Alzheimer's Disease: A Complex Picture of a Multifaceted Disease.

Authors:  Yuniesky Andrade-Talavera; Antonio Rodríguez-Moreno
Journal:  Front Mol Neurosci       Date:  2021-06-17       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.